Molecule Structure

Scientific Name

Tepotinib

Description of the Drug

Tepotinib is an oral tyrosine kinase inhibitor targeted against MET for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB15133

Brand Name(s)

Not Available

Company Owner(s)

Emd Serono Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Hepatocyte growth factor receptor SINGLE PROTEIN INHIBITOR CHEMBL3717

Unichem Links

SureChEMBL SCHEMBL1296895
DrugBank DB15133
PubChem: Thomson Pharma 92728605
PubChem 25171648
LINCS LSM-45557
Nikkaji J3.099.915K
PDBe 3E8
BindingDB 50065457
EPA CompTox Dashboard DTXSID70149132
ChemicalBook CB72550731
Guide to Pharmacology 8293
GSRS 3419708d-1c94-4c4f-8d77-23ca289370a9
ZINC ZINC000043202335